Page last updated: 2024-10-27

fenofibrate and Graves Ophthalmopathy

fenofibrate has been researched along with Graves Ophthalmopathy in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonelli, A2
Ferrari, SM2
Frascerra, S2
Ruffilli, I2
Gelmini, S2
Minuto, M1
Pupilli, C2
Miccoli, P1
Sellari-Franceschini, S2
Ferrannini, E2
Fallahi, P2
Bernini, G1

Other Studies

2 other studies available for fenofibrate and Graves Ophthalmopathy

ArticleYear
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
    Molecular and cellular endocrinology, 2012, Feb-26, Volume: 349, Issue:2

    Topics: Adipocytes; Chemokine CXCL11; Chemokine CXCL9; Enzyme-Linked Immunosorbent Assay; Eye; Fenofibrate;

2012
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
    The Journal of endocrinology, 2012, Volume: 213, Issue:2

    Topics: Cells, Cultured; Chemokine CCL2; Chemokine CXCL10; Fenofibrate; Fibroblasts; Graves Ophthalmopathy;

2012